09:51 AM EST - Lorus Therapeutics Inc. : announced that its second quarter net earnings and other comprehensive income was $2.28 million or $0.01 per share, compared to $2.83 million or $0.01 per share in the year ago quarter. revenues for the quarter rose to $39 thousand, from $1 thousand in the year ago quarter. Lorus Therapeutics Inc.
shares T.LOR are trading down 1 cent at $0.07.